JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miura, K.
Right arrow Articles by Yamamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miura, K.
Right arrow Articles by Yamamoto, K.

Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins

K Miura, T Yukimura, Y Yamashita, T Shimmen, M Okumura, S Yamanaka, M Imanishi and K Yamamoto

Department of Pharmacology, Osaka City University Medical School, Japan.

Vascular responses to endothelin were examined with special reference to prostaglandins (PGs). Intrarenal infusion of endothelin (ET)-1 (1-5 ng/kg/min) to dogs caused a transient increase followed by a sustained decrease in renal blood flow, with no change in blood pressure or heart rate. Renal secretion rates of PGE2 and I2 (determined as 6-keto PGF1 alpha) were increased with ET, dose-dependently, and the intrarenal infusion of ET (5 ng/kg/min) elevated the systemic arterial concentration of 6-keto PGF1 alpha from 26 +/- 5 to 83 +/- 14 pg/ml. Because this increase in PG secretion was not affected by the platelet activating factor antagonist, CV 6209, it is unlikely that ET-induced renal PG production was platelet activating factor-mediated. Pretreatment with aspirin abolished completely the increased PG secretion elicited by ET and potentiated the ET-induced reduction renal blood flow. Intrafemoral infusion of ET (5 ng/kg/min) also induced an initial increase followed by a gradual decrease in femoral blood flow, without any increase in PG secretion from the hindlimb. Aspirin had no effects on the femoral hemodynamic action of ET. In addition, initial transient increases in either renal or femoral blood flow by endothelin were not affected by aspirin. Thus, the ET-induced production of renal PGs counteracts the renal vasoconstrictor action of ET, an event in marked contrast to the lack of any apparent involvement of PGs in the femoral hemodynamic action of ET. The ET-induced transient vasodilation shows no apparent relation to the cyclooxygenase products.

Volume 256, Issue 1, pp. 11-17, 01/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 HypertensionHome page
M. Imanishi, T. Tsuji, S. Nakamura, and M. Takamiya
Prostaglandin I2/E2 Ratios in Unilateral Renovascular Hypertension of Different Severities
Hypertension, July 1, 2001; 38(1): 23 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. C. Hercule and A. O. Oyekan
Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2132 - R2141.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.